The question is more is it worth it to stock domestic raws. The frequency of purchase isn't same as oils and peptides/HGH. So the time we spend at paperwork better spend it on products that sells very fast domestic, with better profit and less risk. One kilo of raws let's say test Cyp sold at $350-$400 domestic will occupy in shipping cost and volume what will occupy 12 kits of tirzepatide 30mg, each will be sold at $600-$700/kit, and probably the same customer will purchase another one the month after, while the raw user might not purchase another test C kilo until it's 1 year later. So just not the priority.